The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ELCC 2021 | The rollout of genomic hubs in the UK
Sanjay Popat, BSc, MBBS, FRCP, PhD, The Royal Marsden NHS Foundation Trust, London, UK, gives an update on the rollout of genetic tumor testing in the UK. Seven genomic laboratory hubs (GLHs) are commissioned to provide germline testing for inheritable cancers and cancer gene testing. Prof. Popat reports that many of these GLHs are now up and running, although testing capacity varies between regions, and emphasizes the importance of genomic testing for patients with lung cancer. This video was recorded at the virtual European Lung Cancer Congress (ELCC) 2021.
